Intellectual Property,
9th U.S. Circuit Court of Appeals
Jul. 27, 2020
9th Circuit panel won’t block California’s pay-to-delay drugs law
The Association for Accessible Medicines, a nonprofit that represents generic drug manufacturers, alleged the bill unconstitutionally attempts to regulate out-of-state commerce, and disrupted the balance between brand-name drug makers and generic and biosimilar competitors.
A federal appeals court on Friday refused to block a California law that penalizes drug companies that pay competitors to delay introducing generics into the market.
The Association for Accessible Medicines, a nonprofit that represents generic drug manufacturers, alleged the bill unconstitutionally attempts to regulate out-of-state commerce, and disrupted the balance between brand-name drug makers and generic and biosimilar competito...
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
Or access this article for $45
(Purchase provides 7-day access to this article. Printing, posting or downloading is not allowed.)
Already a subscriber?
Sign In